Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults
Clinical trial NCT05975840 · COMPLETED
Trial details
- NCT number
- NCT05975840
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-03
- Primary completion
- 2024-05-21
- Enrollment
- 518
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.